'Shark Tank' star Kevin O'Leary: 'You have to save money'
‘Shark Tank’ star Kevin O’Leary has learned something valuable about his employees during the COVID-19 pandemic. …read more […]
‘Shark Tank’ star Kevin O’Leary has learned something valuable about his employees during the COVID-19 pandemic. …read more […]
Robo-advisors are all the rage for some investors. In this Betterment review, we’ll take a close look at how it stacks up against the competition. And while we’re at it, we’ll also compare it to traditional human advisors.
Opening up a Betterment account online is simple. You just need a functioning email address and some basic pieces of information. Once you get in, you do need to provide Betterment with your address, date of birth, tax filing status employment level and income level.
It’s worth noting that to open an account, you also need to provide your social security number. This may …read more […]
Polen Capital Management recently released its Q3 2020 Investor Letter, a copy of which you can download here. During the third quarter of 2020, the Polen Global Growth Composite Portfolio returned 9.09% gross of fees, while the MSCI All Country World Index was up 8.14%. You should check out Polen Capital’s top 5 stock picks […] …read more […]
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of… …read more […]
Polen Capital Management recently released its Q3 2020 Investor Letter, a copy of which you can download here. During the third quarter of 2020, the Polen Global Growth Composite Portfolio returned 9.09% gross of fees, while the MSCI All Country World Index was up 8.14%. You should check out Polen Capital’s top 5 stock picks […] …read more […]
While some are satisfied with an index fund, active investors aim to find truly magnificent investments on the stock… …read more […]
MannKind Corporation (NASDAQ:MNKD) is possibly approaching a major achievement in its business, so we would like to… …read more […]
(Bloomberg Opinion) — Gilead Sciences Inc.’s remdesivir, now under the brand name Veklury, reached another milestone Thursday. It is now the first medicine to get full Food and Drug Administration approval to treat Covid-19. Investors seem to see the nod as a boost to the drug’s prospects, sending shares up more than 4% in early trading Friday after a recent slump. The agency’s decision isn’t likely to dramatically expand the use of the medicine, which has been available to patients through emergency use authorization since May. The data surrounding its modest benefit has become muddier, and it’s not clear why …read more […]
Intel disappointed in its latest quarter, with data center sales falling short. Yahoo Finance’s Alexis Christoforous and Brian Sozzi speak with Santosh Rao of Manhattan Venture Partners about what it means for the chip sector. …read more […]
A look at the shareholders of Lumen Technologies, Inc. (NYSE:LUMN) can tell us which group is most powerful. Generally… …read more […]
Most readers would already be aware that Chart Industries’ (NASDAQ:GTLS) stock increased significantly by 31% over the… …read more […]
Yahoo Finance’s Alexis Christoforous and Brian Sozzi speak with Emily McCormick for the latest on earnings from American Express, Bloomin’ Brands and Intel. …read more […]
The big shareholder groups in Geron Corporation (NASDAQ:GERN) have power over the company. Large companies usually… …read more […]
Thermo Fisher Scientific Inc. (NYSE:TMO) defied analyst predictions to release its third-quarter results, which were… …read more […]
Here’s a look back at some of the most viewed Rigzone articles tied to the downstream from the past week. …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.